AGPS Antikörper (AA 158-384)

Produktnummer ABIN5540330

Dieser Maus Monoklonal Antikörper detektiert spezifisch AGPS in WB und FACS. Es zeigt Reaktivität gegenüber Proben von Human.

Kurzübersicht für AGPS Antikörper (AA 158-384) (ABIN5540330)

Target: AGPS (Alkylglycerone Phosphate Synthase (AGPS))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser AGPS Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Flow Cytometry (FACS)

Klon: AGPS-03

Produktdetails anti-AGPS Antikörper

Bindungsspezifität: AA 158-384

Spezifität: This antibody recognizes AGPS (alkykglycerone phosphate synthase), an peroxisomal enzyme important for lipid biosynthesis.

Aufreinigung: Protein-A affinity chromatography (>95% pure by SDS-PAGE)

Immunogen: Recombinant human AGPS (amino acids 158-384)

Isotyp: IgG2a

Anwendungsinformationen

Applikationshinweise: Flow cytometry. Western blot.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: 95 % pure by SDS-PAGE) Buffer System: Phosphate buffered saline (PBS) Preservatives: 15 mM sodium azide, approx. pH 7.4

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C

Informationen zur Lagerung: Store undiluted at 2-8°C. DO NOT FREEZE! Shelf life: one year from despatch.

Haltbarkeit: 12 months

Details zu AGPS

Target: AGPS (Alkylglycerone Phosphate Synthase (AGPS))

Andere Bezeichnung: agps,aag5

Hintergrund: AGPS (alkylglycerone phosphate synthase), is an enzyme that catalyzes the second step of ether lipid biosynthesis in which acyl-dihydroxyacetone phosphate (acyl-DHAP) is converted to alkyl-DHAP by addition of a long chain alcohol and removal of a long-chain acid anion. The protein is localized to the inner side of the peroxisomal membrane and requires FAD as a cofactor. Mutations in AGPS gene have been associated with type 3 of rhizomelic chondrodysplasia punctata (RCDP3), and Zellweger syndrome. Higher expression of AGPS was observed in BCR/ABL positive leukemias and it was also described to be associated with higher risk of relapse.

UniProt: O00116

Pathways: SARS-CoV-2 Protein Interaktom